Tradestie Institutional Equity Comparison Engine

KALV vs CAPR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

KALV Overall Edge

KALV Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to KalVista Pharmaceuticals, Inc. Common Stock (KALV) driven by superior Valuation, Momentum & Technical while CAPR counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, KALV trades at 25.4x Forward P/E with -57.4% operating margin (+30.7% YoY revenue) versus CAPR at 78.7x Forward P/E and 0.0% operating margin (-7.9% YoY). In options structure, KALV sits in UNCLASSIFIED (31st %ile IV; Dealer Gamma Walls on Pro) against CAPR sits in CONSOLIDATION (89th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner KALV
KALV 25.4x vs CAPR 78.7x Fwd P/E
Growth & Margin Winner CAPR
Op Margin -57.4% vs 0.0% ยท YoY +30.7% vs -7.9%
Momentum & Technical Winner KALV
1Y +82.9% vs +44.3% ยท 52W Pos 100% vs 15%
Options & Structure Winner CAPR
UNCLASSIFIED (31st %ile IV) vs CONSOLIDATION (89th %ile IV)
KALV NASDAQ
KalVista Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$27.00
+0.04% 1D
Market Cap $1.4B
1M Return +1.09%
1Y Return +82.93%
Forward P/E 25.4x
Unified AI Score
55.1 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 57.0 Mom 40.0
CAPR NASDAQ
Capricor Therapeutics Inc
Pharmaceutical Preparations
$8.47
-11.12% 1D
Market Cap $595.4M
1M Return +26.23%
1Y Return +44.29%
Forward P/E 78.7x
Unified AI Score
28.0 / 100 SELL
Tech 50.0 Fund 37.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: KALV +82.93% CAPR +44.29% Spread: +229.12 pp (CAPR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
KALV TTM Op. Margin: -57.4% CAPR TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KALV vs CAPR. Trailing 12-month operating profitability (KALV -57.4% vs CAPR 0.0%) and valuation multiples (KALV 25.4x vs CAPR 78.7x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: KALV (7) vs CAPR (3)
Institutional Metric KALV CAPR Criterion Row Winner
Market Capitalization Scale $1.4B $595.4M Larger Scale KALV
Trailing P/E Ratio Valuation 25.4x 78.7x Lower Multiple KALV
Forward P/E Ratio Valuation 25.4x 78.7x Lower Multiple KALV
Revenue Growth (YoY) Growth +30.7% -7.9% Higher Growth KALV
Operating Margin (TTM) Profitability -57.4% 0.0% Higher Margin CAPR
Net Profit Margin Profitability -118.7% 0.0% Higher Margin CAPR
Return on Equity (ROE) Capital Efficiency -190.2% -100.5% Higher ROE CAPR
52-Week Range Position Momentum 100% ($10โ€“$27) 15% ($3โ€“$40) Stronger Trend KALV
Beta / 30D Volatility Risk Regime 0.85ฮฒ ยท 2% Vol 1.52ฮฒ ยท 152% Vol Lower Realized Risk KALV
Unified Institutional Score Composite Signal 55.1 / 100 (HOLD) 28.0 / 100 (SELL) Higher Composite KALV

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full KALV vs CAPR Buy Guide
KALV UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 31st %ile
IV Regime Balanced (25thโ€“60th %ile)
Live KALV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CAPR CONSOLIDATION
56d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 89th %ile
IV Regime Extreme (>80th %ile)
Live CAPR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither KALV nor CAPR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.